Chronic inflammatory demyelinating polyradiculoneuropathy: Unusual clinical features and therapeutic responses

Neurology

Volumn 46, Issue 5, 1996, Pages 1206-1212

  Midroni, Gyl ^a   Dyck, Peter James ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOGLOBULIN; PREDNISONE;

ADULT; BRACHIAL PLEXUS; BRAIN PSEUDOTUMOR; CASE REPORT; CHRONIC INFLAMMATION; CLINICAL FEATURE; DEMYELINATING DISEASE; HUMAN; IMMUNOMODULATION; INTRACRANIAL PRESSURE; INTRAVENOUS DRUG ADMINISTRATION; LAMINECTOMY; MALE; NERVE ROOT COMPRESSION; PARESTHESIA; PLASMAPHERESIS; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; PUPIL DISEASE; REVIEW; SHUNTING; SPINAL CORD DISEASE; VISUAL IMPAIRMENT;

EID: 0029891224     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.46.5.1206     Document Type: Review

References (27)

1. Dyck PJ, Lais AC, Ohta M, Bastron JA, Okazaki H, Groover RV. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 1975;50:621-637.
2. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR. Chronic inflammatory demyelinating polyradiculoneuropathy: clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 1989;46:878-884.
3. McCombe PA, Pollard JD, McLeod JG. Chronic inflammatory demyelinating polyradiculoneuropathy. Brain 1987;110:1617-1630.
4. Austin JH. Observations on the syndrome of hypertrophic neuritis (the hypertrophic interstitial radiculo-neuropathies). Medicine 1956;35:187-237.
5. Harris WD, Newcomb WD. A case of relapsing interstitial hypertrophic polyneuritis. Brain 1929;52:108-116.
6. Symonds CP, Blackwood W. Spinal cord compression in hypertrophic neuritis. Brain 1962;85:251-260.
7. Dyck PJ, Sherman WR, Hallcher LM, et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 1980;8:590-596.
8. Fantin A, Feist RM, Reddy CV. Intracranial hypertension and papilloedema in chronic inflammatory demyelinating polyneuropathy. Br J Ophthalmol 1993;77:193.
9. Buchsbaum HW, Gallo AE Jr. Polyneuritis, papilledema, and lumboperitoneal shunt. Arch Neurol 1969;21:253-257.
10. Garcin R, Gruner J, Man HX. Documents pour servir a l'etude pathogenique du signe d'Argyll-Robertson dans la nevrite hypertrophique de Dejerine-Sottas. Bull Acad Natl Med 1959; 143:499-508.
11. Adams RD, Asbury AK, Michelsen JJ. Multifocal pseudohypertrophic neuropathy. Trans Am Neurol Assoc 1965;90:30-34.
12. Rosen SA, Wang H, Cornblath DR, Uematsu S, Hurko O. Compression syndromes due to hypertrophic nerve roots in hereditary motor sensory neuropathy type I. Neurology 1989; 39:1173-1177.
13. De Silva RN, Willison HJ, Doyle D, Weir AI, Hadley DM, Thomas AM. Nerve root hypertrophy in chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 1994;17:168-170.
14. Ginsberg L, Platts AD, Thomas PK. Chronic inflammatory demyelinating polyneuropathy mimicking a lumbar spinal stenosis syndrome. J Neurol Neurosurg Psychiatry 1995;59: 189-191.
15. Bertorini T, Halford H, Lawrence J, Vo D, Wassef M. Contrast-enhanced magnetic resonance imaging of the lumbosacral roots in the dysimmune inflammatory polyneuropathies. J Neuroimaging 1995;5:9-15.
16. Cusimano MD, Bilbao JM, Cohen SM. Hypertrophic brachial plexus neuritis: A pathological study of two cases. Ann Neurol 1988;24:615-622.
17. Lewis RA, Sumner AJ, Brown MJ, Asbury AK. Multifocal demyelinating neuropathy with persistent conduction block. Neurology 1982;32:958-964.
18. Bradley WG, Bennet RK, Good P, Little B. Proximal chronic inflammatory polyneuropathy with multifocal conduction block. Arch Neurol 1988;45:451-455.
19. Donofrio PD, Tandan R, Albers JW. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1985;8:321-327.
20. Gibbels E, Toyka KV, Borberg H, Haupt WF, Hann P. Plasmaaustauschbehandlung bei chronischen polyneuritiden vom typ Guillain-Barre. Nervenarzt 1986;57:129-139.
21. Van Doom PA, Vermeulen M, Brand A, Mulder PGH, Busch HFM. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: clinical and laboratory characteristics associated with improvement. Arch Neurol 1991;48:217-220.
22. Dyck PJ, Daube J, O'Brien P, et al. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 1986;314:461-465.
23. Dyck PJ, Litchy WJ, Kratz KM, et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 1994; 36:838-845.
24. Dyck PJ, O'Brien PC, Oviatt KF, et al. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 1982;11:136-141.
25. Vermeulen M, van Doom PA, Brand A, Strengers PF, Jennekens FG, Busch HF. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 1993;56:36-39.
26. Dyck PJ, Kratz KM, Lehman KA, et al. The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 1991;41:799-807.
27. Dyck PJ, Litchy WJ, Lehman KA, Hokanson JL, Low PA, O'Brien PC. Variables influencing neuropathic endpoints: The Rochester diabetic neuropathy study of healthy subjects. Neurology 1995;45:1115-1121.